Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures

[1]  G. González-Aseguinolaza,et al.  Gene Therapy for Acquired and Genetic Cholestasis , 2022, Biomedicines.

[2]  S. Alam,et al.  Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies , 2022, World journal of hepatology.

[3]  A. Al-Hussaini,et al.  ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations associated with cholestasis with Different phenotypes and Outcomes. , 2021, The Journal of pediatrics.

[4]  R. Płoski,et al.  Progressive familial intrahepatic cholestasis type 3: report of four clinical cases, novel ABCB4 variants, and long-term follow-up. , 2021, Annals of hepatology.

[5]  Z. Duan,et al.  A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report , 2021, Annals of translational medicine.

[6]  P. An,et al.  Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4−/− mouse model of PFIC3 , 2020, Journal of hepatology.

[7]  Wen Zhang,et al.  Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China , 2020, Pediatric gastroenterology, hepatology & nutrition.

[8]  J. Bai,et al.  Evaluation of a Novel Missense Mutation in ABCB4 Gene Causing Progressive Familial Intrahepatic Cholestasis Type 3 , 2020, Disease markers.

[9]  M. Trauner,et al.  Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. , 2020, Journal of hepatology.

[10]  B. Cavdarli,et al.  A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis , 2020, Journal of pediatric endocrinology & metabolism : JPEM.

[11]  Francesco Raimondi,et al.  Familial intrahepatic cholestasis: New and wide perspectives. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  L. Schmitt,et al.  ABCB4/MDR3 in health and disease – at the crossroads of biochemistry and medicine , 2019, Biological chemistry.

[13]  Richard J. Thompson,et al.  Progressive Familial Intrahepatic Cholestasis. , 2018, Clinics in liver disease.

[14]  V. Barbu,et al.  Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[15]  Mei-Hwei Chang,et al.  Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases , 2018, Journal of Biomedical Science.

[16]  Li Guo,et al.  [Clinical and genetic analysis of a family affected by progressive familial intraphepatic cholestasis type 3]. , 2018, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[17]  F. Lammert,et al.  Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset , 2018, Hepatology communications.

[18]  K. Kowdley,et al.  New developments in the treatment of primary biliary cholangitis – role of obeticholic acid , 2017, Therapeutics and clinical risk management.

[19]  R. Houwen,et al.  Current and future therapies for inherited cholestatic liver diseases , 2017, World journal of gastroenterology.

[20]  I. Callebaut,et al.  Functional defect of variants in the adenosine triphosphate–binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX‐770) , 2017, Hepatology.

[21]  H. Gee,et al.  Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3 , 2016, Scientific Reports.

[22]  C. Dossier,et al.  A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3 , 2016, Hepatology.

[23]  C. Housset,et al.  A PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression , 2016, PloS one.

[24]  A. Lonardo,et al.  Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test , 2016, The Indian journal of medical research.

[25]  M. Saadeh,et al.  Liver , 2016, Laboratory Investigation.

[26]  D. Jain,et al.  Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment , 2015, Pediatric gastroenterology, hepatology & nutrition.

[27]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[28]  W. Ding,et al.  Role of farnesoid X receptor and bile acids in alcoholic liver disease , 2015, Acta pharmaceutica Sinica. B.

[29]  Haoran Sun,et al.  Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3. , 2015, World journal of gastroenterology.

[30]  C. Housset,et al.  ABCB4: Insights from pathobiology into therapy. , 2014, Clinics and research in hepatology and gastroenterology.

[31]  P. Jara,et al.  Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity , 2014, Gut.

[32]  Anshu Srivastava,et al.  Progressive familial intrahepatic cholestasis. , 2014, Journal of clinical and experimental hepatology.

[33]  M. Rastaldi,et al.  Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction , 2013, European Journal of Human Genetics.

[34]  D. Häussinger,et al.  The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3. , 2012, Gene.

[35]  Li-yan Liu,et al.  Chinese Children With Chronic Intrahepatic Cholestasis and High &ggr;-Glutamyl Transpeptidase: Clinical Features and Association With ABCB4 Mutations , 2012, Journal of pediatric gastroenterology and nutrition.

[36]  M. Finegold,et al.  Progressive Familial Intrahepatic Cholestasis Type 3 , 2012, Clinical pediatrics.

[37]  F. Callea,et al.  Two novel mutations in African and Asian children with progressive familial intrahepatic cholestasis type 3. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[38]  J. Bode,et al.  Cholestatic Liver Diseases from Child to Adult: The Diversity of MDR3 Disease , 2011, Zeitschrift fur Gastroenterologie.

[39]  D. Consonni,et al.  Clinical Features and Genotype-Phenotype Correlations in Children With Progressive Familial Intrahepatic Cholestasis Type 3 Related to ABCB4 Mutations , 2011, Journal of pediatric gastroenterology and nutrition.

[40]  E. Jacquemin,et al.  The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. , 2010, Seminars in liver disease.

[41]  E. Jacquemin,et al.  Progressive familial intrahepatic cholestasis , 2009, Orphanet journal of rare diseases.

[42]  M. Burdelski,et al.  Liver transplantation in children with progressive familial intrahepatic cholestasis. , 2007, Transplantation.

[43]  M. Seia,et al.  Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3) , 2007, European Journal of Human Genetics.

[44]  K. Ueda,et al.  Bile salt–dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4 , 2007, Hepatology.

[45]  C. Paulusma,et al.  Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein) , 2007, Pflügers Archiv - European Journal of Physiology.

[46]  R. Houwen,et al.  Genetics of familial intrahepatic cholestasis syndromes , 2005, Journal of Medical Genetics.

[47]  D. Jensen,et al.  Serum enzymes associated with cholestasis. , 2004, Clinics in liver disease.

[48]  L. Frulloni,et al.  Progressive familial intrahepatic cholestasis. , 2002, Acta bio-medica : Atenei Parmensis.

[49]  Y. Jeng,et al.  Progressive Familial Intrahepatic Cholestasis with High γ-Glutamyltranspeptidase Levels in Taiwanese Infants: Role of MDR3 Gene Defect? , 2001, Pediatric Research.

[50]  P. Bosma,et al.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. , 2001, Gastroenterology.